Skip to main content
Log in

2-Methoxyoestradiol levels and placental catechol-O-methyltransferase expression in patients with late-onset preeclampsia

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Deficiencies in placental catechol-O-methyltransferase (COMT) and circulating 2-methoxyoestradiol (2-ME) have been shown to be related to early onset preeclampsia. The aim of this study was to investigate levels of 2-ME in the serum and urine of patients with late-onset preeclampsia and to compare those levels to those of normal pregnant women. In addition, we examined placental COMT expression in both groups.

Methods

Fifteen patients with preeclampsia and 15 normal pregnant women were enrolled. 2-ME levels were evaluated by ELISA and placental COMT expression was examined by Western blot analysis.

Results

2-ME levels in serum [median 181.1 pg/mL, interquartile range (IQR) 119.6–244.3 vs. 61.2 pg/mL, IQR 12.0–133.7, respectively, p = 0.004] and urine (median 143.3 pg/mL, IQR 35.0–328.2 vs. 0.5 pg/mL, IQR 0.4–4.6, respectively, p < 0.001) were significantly increased in patients with late-onset preeclampsia compared to those in normal pregnant women at term. There was no significant difference in placental COMT expression between the two groups.

Conclusion

Increased levels of 2-ME in patients with late-onset preeclampsia might be a product of a compensatory mechanism in patients with late-onset preeclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365(9461):785–799

    PubMed  Google Scholar 

  2. Roberts JM, Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357(9249):53–56

    Article  PubMed  CAS  Google Scholar 

  3. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G (2002) Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 186(1):66–71

    Article  PubMed  Google Scholar 

  4. Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51(4):970–975

    Article  PubMed  CAS  Google Scholar 

  5. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R (2008) Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453(7198):1117–1121

    Article  PubMed  CAS  Google Scholar 

  6. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3(4):363–375

    Article  PubMed  CAS  Google Scholar 

  7. Vatten LJ, Skjaerven R (2004) Is pre-eclampsia more than one disease? BJOG 111(4):298–302

    Article  PubMed  Google Scholar 

  8. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano PM, Morris CD (2000) Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol 95(1):24–28

    Article  PubMed  CAS  Google Scholar 

  9. Kenneth L, Hall DR, Gebhardt S, Grove D (2010) Late onset preeclampsia is not an innocuous condition. Hypertens Pregnancy 29(3):262–270

    Article  PubMed  CAS  Google Scholar 

  10. Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y (2010) Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG 117(3):314–320

    Article  PubMed  CAS  Google Scholar 

  11. Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG (2004) Second trimester doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 106(4):377–382

    Article  CAS  Google Scholar 

  12. ACOG practice bulletin (2002) Diagnosis and management of preeclampsia and eclampsia. Number 33. Obstet Gynecol 99(1):159–167

    Article  Google Scholar 

  13. D’Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91(9):3964–3968

    Article  PubMed  Google Scholar 

  14. Salama SA, Kamel MW, Botting S, Salih SM, Borahay MA, Hamed AA, Kilic GS, Saeed M, Williams MY, Diaz-Arrastia CR (2009) Catechol-O-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells. PLoS One 4(10):e7356

    Article  PubMed  Google Scholar 

  15. Lee SB, Wong AP, Kanasaki K, Xu Y, Shenoy VK, McElrath TF, Whitesides GM, Kalluri R (2010) Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol 176(2):710–720

    Article  PubMed  CAS  Google Scholar 

  16. Hertig A, Liere P, Chabbert-Buffet N, Fort J, Pianos A, Eychenne B, Cambourg A, Schumacher M, Berkane N, Lefevre G, Uzan S, Rondeau E, Rozenberg P, Rafestin-Oblin ME (2010) Steroid profiling in preeclamptic women: evidence for aromatase deficiency. Am J Obstet Gynecol 203(5):477.e1–e9

    Article  Google Scholar 

  17. Barnea ER, MacLusky NJ, DeCherney AH, Naftolin F (1988) Catechol-O-methyl transferase activity in the human term placenta. Am J Perinatol 5(2):121–127

    Article  PubMed  CAS  Google Scholar 

  18. Palmer K, Saglam B, Whitehead C, Stock O, Lappas M, Tong S (2011) Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression. Am J Pathol 178(6):2484–2488

    Article  PubMed  CAS  Google Scholar 

  19. Ghidini A, Salafia CM, Pezzullo JC (1997) Placental vascular lesions and likelihood of diagnosis of preeclampsia. Obstet Gynecol 90(4 Pt 1):542–545

    Article  PubMed  CAS  Google Scholar 

  20. Roten LT, Fenstad MH, Forsmo S, Johnson MP, Moses EK, Austgulen R, Skorpen F (2011) A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 17(7):439–446

    Article  PubMed  CAS  Google Scholar 

  21. Hill LD, York TP, Kusanovic JP, Gomez R, Eaves LJ, Romero R, Strauss JF 3rd (2011) Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS One 6(1):e16681

    Article  PubMed  CAS  Google Scholar 

  22. Lim JH, Kim SY, Kim do J, Park SY, Han HW, Han JY, Lee SW, Yang JH, Ryu HM (2010) Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17alpha in preeclampsia. Pharmacogenet Genomics 20(10):605–610

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Min-Jeong Oh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seol, HJ., Cho, GJ., Oh, MJ. et al. 2-Methoxyoestradiol levels and placental catechol-O-methyltransferase expression in patients with late-onset preeclampsia. Arch Gynecol Obstet 287, 881–886 (2013). https://doi.org/10.1007/s00404-012-2663-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-012-2663-1

Keywords

Navigation